Catalyst Pharmaceuticals (CPRX) Q3 2024 Earnings

7AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
0.19
0.29
0.39
0.49

Details

Expected EPS
0.228
Actual EPS
0.33
Surprise EPS
0.1
Surprise Percent
+44.74%

Description

Catalyst Pharmaceuticals (CPRX) has reported earnings of 0.33 per share for Q3 2024.

0 Comments

Share your thoughts